business
COMPANY BENCHMARKING • UNITED STATES

Bausch Health Companies Inc. - Company Profile

Access all 5,000+ company profiles through Benchmarking Pro, available to Membership Plus subscribers. Unlock interactive competitor comparison tools that show you how Bausch Health Companies Inc. stacks up to the competition and put relevant competitor and industry information at your fingertips.


Bausch Health Companies Inc. - Overview

Brands
Artelac, Biotrue, Boston, Ocuvite, PreserVision, ReNu Multiplus, SootheXP
Description
Bausch Health Companies Inc. is a public company headquartered in Quebec with an estimated 19,600 employees. In the US, the company has a notable market share in at least three industries: Ophthalmic Instrument Manufacturing, Contact Lens Manufacturing and Glasses & Contact Lens Manufacturing. Their largest market share is in the Ophthalmic Instrument Manufacturing industry, where they account for an estimated 13.9% of total industry revenue and are considered a Laggard because they display lower market share alongside slower profit and revenue growth than their peers.
Company Details

Registered Name: Bausch Health Companies Inc.

Company Type: Operating

Exchange: NYSE

Headquarters: 2150 St. Elzear Blvd. West Laval Quebec A8 H7L 4A8

Employees: 19600

Bausch Health Companies Inc. - Operating Industries and Main Competitors

error_outline To view all of Bausch Health Companies Inc.'s operating industries and competitors, see purchase options.

Bausch Health Companies Inc. - Products and Services

  • Contact Lens Manufacturing

  • Of the 4 core revenue-generating products and services in the Contact Lens Manufacturing industry, Bausch Health Companies Inc. offers:
    • Multifocal lenses
    • Other lenses and products
    • Single vision spherical lenses
    • AAAAA AAAAA
  • Ophthalmic Instrument Manufacturing

  • Of the 3 core revenue-generating products and services in the Ophthalmic Instrument Manufacturing industry, Bausch Health Companies Inc. offers:
    • Diagnostic equipment
    • Laser surgical equipment
    • Surgical systems and instruments
error_outline To view Bausch Health Companies Inc.'s full products and services, see purchase options.

Bausch Health Companies Inc. - Analyst Insights

JUBLIA approved by the APMA, enabling Bausch subsidiary to launch

Bausch Health Companies Inc. announced in 2021 that Ortho Dermatologics, the company’s dermatology business, has been approved to launch JUBLIA, a treatment solution for onychomycosis. Reviewed by the American Podiatric Medical Association (APMA), the new product has undergone significant scientific reviews relating to the product’s safety and effectiveness.

Product Innovation|New Activity


In response to volatile demand in the wake of the first COVID-19 surge, the company undertook a comprehensive cost reduction program, aimed at shoring up labor and supply costs.

Lorem Ipsum text header Report Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Maecenas non leo lacinia, consectetur ipsum non, pretium augue. Vestibulum accumsan dignissim massa, eu scelerisque mi malesuada ut. Aliquam scelerisque facilisis nisl ac varius. Nunc luctus nunc vel eros iaculis, vitae tristique ante fringilla. Ut vitae vulputate est, vel lacinia nisi. Curabitur eget nulla vitae mi faucibus imperdiet. Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

Cras sagittis arcu eu diam pharetra iaculis eget sit amet risus. Morbi eget turpis ut diam commodo congue id eu lacus.

error_outline To view all analyst insights on Bausch Health Companies Inc., see purchase options.

Bausch Health Companies Inc. - SWOT Analysis

Strengths and weaknesses take into account internal factors, and are based on Bausch Health Companies Inc.'s performance in comparison to its competitors. Opportunities and Threats focus on external influences, and are based on trends and demand in the Glasses & Contact Lens Manufacturing in the US, Contact Lens Manufacturing, and Ophthalmic Instrument Manufacturing industries.
Strengths
Days Receivables: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Annual Turnover: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Weaknesses
Credit Risk: x.x%
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Revenue per Employee: $xx
Purchase a membership to unlock the full SWOT analysis of this company.
lock
Rank: 2 of 3 peers
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Opportunities
  • AAAAA
  • AAAAA
  • AAAAA
Threats
  • AAAAA
  • AAAAA
  • AAAAA

error_outline To view Bausch Health Companies Inc.'s full SWOT analysis, see purchase options.

Bausch Health Companies Inc. - Financial Statements & Ratios

pie_chartBausch Health Companies Inc. Income Statement

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/201712/31/2016
Revenue8,434.08,027.08,601.08,380.08,724.09,674.0
Cost of Revenue000000000000000000000000
Cost of Revenue, Non-Cash000000000000000000000000
Gross Profit000000000000000000000000
AAAAAA AAAAAA000000000000000000000000

pie_chartBausch Health Companies Inc. Balance Sheet

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/201712/31/2016
Cash and Equivalents582.0605.03,243.0721.0720.0542.0
Short-Term Investments000000000000000000000000
Derivative Assets, Current000000000000000000000000
Restricted Cash and Investments000000000000000000000000
AAAAAA AAAAAA000000000000000000000000

pie_chartBausch Health Companies Inc. Cash Flow

BALANCE DATE12/31/202112/31/202012/31/201912/31/201812/31/201712/31/2016
Net Income-937.0-559.0-1,783.0-4,144.02,404.0-2,408.0
Income (Loss) From Discontinued Operations000000000000000000000000
Depreciation, Depletion and Amortization000000000000000000000000
Amortization of Financing Costs and Discounts000000000000000000000000
AAAAAA AAAAAA000000000000000000000000

error_outline To view Bausch Health Companies Inc.'s full competitive environment, see purchase options.

GET INSTANT ACCESS WITH MEMBERSHIP PLUS

100% Money Back Guarantee Digicert Trusted

BENCHMARKING PRO

What's Inside
Benchmarking Pro?

Available with US Membership Plus packages, this suite of company and industry data:

Benchmarks companies against industry averages or like-sized segments, as well as close competitors
Identifies real-world strengths, opportunites, weaknesses and threats
Reveals growth opportunities or red flags in a business growth strategy

Included in Report

  • Enterprise History & Synopsis
    Enterprise History & Synopsis
  • Enterprise Financial Statements
    Company Financial Statements
  • Financial Ratios
    Industry Market Share Breakdown
  • Industry Averages
    Industry Competitor Matrix
  • Competitive Landscape
    SWOT Analysis
  • Key Enterprise Personnel
    Products and Services
  • Subsidiaries & Ownership Structure
    Key Company Benchmarks

Why purchase access to Benchmarking Pro?

This profile on Bausch Health Companies Inc. includes:

  • Company Overview
  • Company Revenue and Employee Data
  • Company Financial Statements
  • Industry Market Share Breakdown
  • Industry Competitor Matrix
  • SWOT Analysis
  • Products and Services
  • Key Company Benchmarks
  • Interconnected Competitor Profiles and Industry Reports
  • Full Access to Benchmarking Pro

The IBISWorld Benchmarking Pro solution enables you to:

  • Understand a enterprise’s competitive landscape and how they perform within a like-sized industry segment.
  • Benchmark companies against industry averages, segment averages and their competitors.
  • Identify real-world strengths, opportunities, weaknesses and threats for companies.
  • Target growth opportunities or spot red flags in a business growth strategy.
  • Toggle between company profiles and industry reports for a 360 degree view of a company's position.

IBISWorld provides profiles on thousands of leading companies around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends across all sectors of the economy. This company profile, along with the corresponding competitor and industry data provided, includes thoroughly researched, reliable and current information that will help you to make faster, better business decisions.

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal